Active Ingredient History

  • Now
APREMILAST, (±)- is a mixture of isomers, one of them is therapeutic active S form (apremilast), an inhibitor of phosphodiesterase 4. This active form is sold under the brand name OTEZLA for the treatment of adult patients with active psoriatic arthritis.   NCATS

  • SMILES: CCOC1=C(OC)C=CC(=C1)C(CS(C)(=O)=O)N2C(=O)C3=C(C2=O)C(NC(C)=O)=CC=C3
  • Mol. Mass: 460.5
  • ALogP: 2.43
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$41.2063 - $62.3862
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

apremilast | aprémilast | apremilastum | cc-100004 | cc10004 | cc 10004 | cc-10004 | n-{2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1h-isoindol-4-yl}acetamide | otezla


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue